The Division of Thoracic Surgery at Brigham and Women’s Hospital (BWH) began providing oncology treatment for patients with cancer of the lungs and chest over 25 years ago. Our innovative program—the first of its kind in the United States—continues to grow in size and reputation. Now, under The Lung Center, our cancer programs include a team of medical and surgical specialists providing integrated care for every type of lung and chest cancer.
The Lung Center at BWH combines the clinical and research expertise of a team of medical oncologists, radiation oncologists, thoracic surgeons and pulmonologists. Physicians and specialists from the Divisions of Thoracic Surgery, Pulmonary and Critical Care Medicine, and the Lowe Center for Thoracic Oncology within Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC), work closely together, delivering the latest advancements in the prevention, diagnosis and treatment of lung and chest cancers. These board-certified physicians not only specialize in thoracic cancers, but are engaged in medical research in these same areas, developing innovative medical and surgical approaches that improve patient outcomes and quality of life.
With close attention to patient and family needs, we educate patients about their specific type of cancer and treatment options so they can make informed decisions. We offer a range of supportive services, including nutritional counseling, emotional and spiritual support, financial advice and complementary therapies, such as acupuncture and massage. Our goal is to treat the whole person throughout the cancer experience—from diagnosis to treatment to recovery.
Chest and Lung Cancer Programs
Chest Wall Cancer Services
Cancers of the chest wall are relatively rare and difficult to treat. Our multidisciplinary team has significant expertise in managing patients with complex chest wall tumors. Learn more about Chest Wall Cancer Services.
Lung Cancer Diagnostic and Screening Clinic
Our imaging and oncology specialists have developed innovative methods for screening and diagnosing lung cancer and optimizing individualized approaches to treat and advise patients with newly identified lung nodules. Learn more about the Lung Cancer Diagnostic and Screening Clinic.
We have developed expertise in the management of all mediastinal tumors (located in the area of the chest that separates the lungs), including thymoma and other thymic cancers. Our program, which includes a multidisciplinary team of experts, offers a number of innovative surgical treatments and clinical trials. Learn more about Mediastinal Tumors.
The International Mesothelioma Program (IMP) is one of the largest of its kind in the world. It provides focused and holistic care for all patients with mesothelioma, a rare form of cancer that most commonly affects the outer lining of the lungs and internal chest wall. Learn more about the International Mesothelioma Program.
Focused treatment of metastatic disease—cancer that has spread to the lungs after starting in another part of the body—requires specialty care. We utilize state-of-the-art molecular diagnostics and surgical resection or advanced, precise radiologic ablation. Learn more about Metastasis.
Pleural Effusion Services
Pleural and pericardial effusions (excess fluid) are common complications of cancer. We have experience treating hundreds of patients with effusions annually and bring our expertise to individual patients to help alleviate their symptoms. Learn more about Pleural Effusion Services.
Thoracic Oncology Program
Thoracic surgeons specialize in lung cancer, esophageal cancer, mesothelioma, thymoma, airway malignancies and other cancers within the chest. They are the thoracic surgical team for Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). Learn more about the Thoracic Oncology Program.
Women’s Lung Cancer Program
With a focused history on women’s health, we have established a specialized women's lung cancer program to support and treat specific gender-related issues for women facing lung cancer. Learn more about the Women’s Lung Cancer Program.
Chest and Lung Cancer Leadership Team
This page was last modified on 9/15/2016